| Canonical PRC1 controls sequence-independent propagation of Polycomb-mediated gene silencing HF Moussa, D Bsteh, R Yelagandula, C Pribitzer, K Stecher, K Bartalska, ... Nature communications 10 (1), 1931, 2019 | 72 | 2019 |
| Parallel PRC2/cPRC1 and vPRC1 pathways silence lineage-specific genes and maintain self-renewal in mouse embryonic stem cells JA Zepeda-Martinez, C Pribitzer, J Wang, D Bsteh, S Golumbeanu, ... Science advances 6 (14), eaax5692, 2020 | 45 | 2020 |
| Discovery and characterization of a cellular potent positive allosteric modulator of the polycomb repressive complex 1 chromodomain, CBX7 KN Lamb, D Bsteh, SN Dishman, HF Moussa, H Fan, JI Stuckey, JL Norris, ... Cell chemical biology 26 (10), 1365-1379. e22, 2019 | 44 | 2019 |
| Reprogramming CBX8-PRC1 function with a positive allosteric modulator JL Suh, D Bsteh, B Hart, Y Si, TM Weaver, C Pribitzer, R Lau, S Soni, ... Cell chemical biology 29 (4), 555-571. e11, 2022 | 15 | 2022 |
| Loss of cohesin regulator PDS5A reveals repressive role of Polycomb loops D Bsteh, HF Moussa, G Michlits, R Yelagandula, J Wang, U Elling, O Bell Nature Communications 14 (1), 8160, 2023 | 4 | 2023 |
| Baseline circulating tumor cell (CTC) count as a prognostic marker of overall survival (OS) in metastatic hormone sensitive prostate cancer (mHSPC): Results from SWOG S1216, a … A Goldkorn, C Tangen, M Plets, D Bsteh, T Xu, JK Pinski, S Ingles, ... Journal of Clinical Oncology 41 (16_suppl), 5080-5080, 2023 | 1 | 2023 |
| m6A epitranscriptome analysis reveals differentially methylated transcripts that drive early chemoresistance in bladder cancer E Hodara, A Mades, L Swartz, M Iqbal, T Xu, D Bsteh, PJ Farnham, ... NAR cancer 5 (4), zcad054, 2023 | | 2023 |
| HERCULES: A prostate cancer (PC) sequencing panel for parallel analysis of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs). D Bsteh, J Buckley, D Ostrow, JH Parmentier, S Maganti, S Mitchell, ... Journal of Clinical Oncology 41 (16_suppl), 5036-5036, 2023 | | 2023 |
